-
Johnson & Johnson Updates U.S. COVID-19 Vaccine Fact Sheet
Date last updated: 05/05/2022
-
Identifying Authentic Janssen HIV Medicines
Date last updated: 04/26/2022
-
Janssen Takes Action to Remove Counterfeit HIV Medicines from the United States Supply Chain
Date last updated: 04/26/2022
-
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
Date last updated: 01/06/2022
-
Oncology Conferences
Date last updated: 05/04/2022
-
Neuroscience Conferences
Date last updated: 05/03/2022
-
Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant
Date last updated: 12/30/2021
-
HIV Conferences
Date last updated: 11/11/2021
-
U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines
Date last updated: 10/21/2021
-
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
Date last updated: 10/20/2021
-
Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
Date last updated: 10/15/2021
-
Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine
Date last updated: 10/08/2021
-
Cardiovascular & Metabolism Conferences
Date last updated: 02/16/2022
-
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
Date last updated: 09/21/2021
-
Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine
Date last updated: 08/25/2021
-
Johnson & Johnson Statement on U.S. FDA Approval of Shelf Life Extension for Company’s COVID-19 Vaccine
Date last updated: 08/27/2021
-
Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
Date last updated: 07/14/2021
-
Johnson & Johnson Statement on COVID-19 Vaccine (7/12)
Date last updated: 07/13/2021
-
Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
Date last updated: 07/02/2021
-
Janssen COVID-19 Vaccine (Ad26.COV2.S) EUA Approval Press Release
Date last updated: 02/27/2021
